takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Tadataka Yamada M.D., Ph.D.
|Age||Total Calculated Compensation||This person is connected to 122 board members in 8 different organizations across 12 different industries.|
See Board Relationships
As of Fiscal Year 2015
Dr. Tadataka Yamada, also known as Tachi, Ph.D., M.D. has been a Venture Partner of Life Sciences team and Senior Advisor of growth buyout team at Frazier Healthcare since July 6, 2015. Dr. Yamada serves as a Corporate Officer and Head of Emerging Markets Commercial Operations at Nycomed A/S. He served as Chief Medical & Scientific Officer at Takeda Pharmaceutical Company Limited from November 2011 to June 2015. He served as an Executive Director of GlaxoSmithkline Plc ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
Independent Board Member
New York University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|